Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PFRM3.SA
Strong BuyProfarma Distribuidora de Produtos Farmacêuticos S.A. · Healthcare · Brazil · $179M · Avg Vol: $212K/d
COMPANY DESCRIPTION
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It offers pharmaceutical, personal hygiene, and beauty products.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 7.8B | 8.7B | 10.2B | 11.5B | 13.6% | 12.6B |
| EPS (BRL) | 0.66 | 0.57 | 0.93 | 0.97 | 13.7% | 1.27 |
| Shares | 122.6M | 122.6M | 122.6M | 122.6M | -0.0% | 122.6M |
| Debt | 1.0B | 1.1B | 1.2B | 1.4B | 11.0% | 1.9B |
| Equity | 1.2B | 1.2B | 1.3B | 1.3B | 4.2% | — |
| Op CF | 126.3M | 260.9M | 497.1M | 459.7M | 53.8% | 579.5M |
| Inv CF | -21.7M | -96.6M | -136.8M | -176.1M | — | — |
| Fin CF | -109.8M | -153.8M | -324.4M | -278.0M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PFRM3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A.(you) | $179M | 98 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 87 | Strong Buy |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $62M | 95 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
| BIOM3.SA | Biomm S.A. | $180M | 43 | Hold |
Peer medians: ROE 10.6% · P/E 13.3x · Gross margin 31.0%